Table 3.
eGFR evolution.
| Period | Entire cohort (± SD) | Baseline proteinuria < 2 g/d (± SD) | Baseline proteinuria 2–3.5 g/d (± SD) | Baseline proteinuria > 3.5 g/d (± SD) | Baseline eGFR ≥ 60ml/min (± SD) | Baseline eGFR < 60ml/min (± SD) |
|---|---|---|---|---|---|---|
| Baseline | 59 ± 24 | 55.1 ± 23.3 | 64.5 ± 30.1 | 74 ± 19.8 | 77.8 ± 18.2 | 39.3 ± 12.5 |
| 3 mo | 61.1 ± 26.8 | 56 ± 24.9 | 70 ± 35.5 | 69 ± 8.5 | 76 ± 24.2 | 44.2 ± 18.7 |
| 6 mo | 63.3 ± 25.5 | 58.1 ± 25.9 | 68.8 ± 25.8 | 78.5 ± 19 | 78.2 ± 21.2 | 46.4 ± 18.9 |
| 12 mo | 62.6 ± 28.1 | 53.4 ± 25.7 | 73.7 ± 28.1 | 86.5 ± 21.9 | 80 ± 23.4 | 42.9 ± 18.4 |
| 15 mo | 60.8 ± 26 | 57.3 ± 26.6 | 65.3 ± 28.2 | 71 ± 20.9 | 77.3 ± 20.4 | 43.3 ± 19.2 |
| 18 mo | 65.1 ± 30.8 | 58.5 ± 29.1 | 73.5 ± 38.9 | 83.2 ± 13.9 | 86.1 ± 22.9 | 42.6 ± 20.7 |
| 24 mo | 62.2 ± 30.6 | 57.8 ± 28 | 68.4 ± 43.5 | 73.2 ± 14.4 | 81.7 ± 26.7 | 41.3 ± 18.3 |
| 36 mo | 59.6 ± 25.7 | 56.6 ± 29.3 | 57 ± 4.3 | 74.5 ± 9.9 | 77.1 ± 17.3 | 42.1 ± 20.2 |
| Percentage change (95%CI) | ||||||
| 12 mo | + 7.68% (− 4.7, 20.1) | − 0.41% (− 16.2, 15.4) | + 20.7% (− 6.4, 47.8) | + 22.1% (− 39.1, 83.4) | + 4.44 (− 10.2, 19.1) | + 11.3 (− 11.4, 34.1) |
| 24 mo | + 7.42% (− 7.23, 22.1) | + 6.75% (− 14, 27.5) | + 11.9% (− 21.5, 45.5) | + 2.92% (− 41.1, 47) | + 8.06% (− 5.7, 21.8) | + 6.7% (− 22, 35.5) |
| 36 mo | + 4.74% (− 13.5, 23) | + 4.61% (− 21.4, 30.6) | − 3.23% (− 38, 50) | + 4.1% (− 31, 39.3) | + 3.53% (− 5.5, 12.6) | + 5.95% (− 32.7, 44.6) |
eGFR estimated glomerular filtration rate, mo months, SD standard deviation, CI confidence interval.